Author

Nikolai Petrovsky

Vaxine (Australia)ORCID 0000-0002-1580-5245Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:imaging· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Alexandra FrancianiD· 1 shared Appavu K. SundaramiD· 1 shared April T. DavenportiD· 1 shared Bryce ChackerianiD· 1 shared Christopher S. GambleiD· 1 shared Daniel F. EwingiD· 1 shared Dwayne W. GodwiniD· 1 shared Fidel P. ZavalaiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexandra FrancianORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyAntiviral ResearchPeer-reviewedJul 15, 2025

SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody

Mikhail Y. Lebedin, Nikolai Petrovsky, Kairat Tabynov…·Yuri S. Lebedin

This study identifies a humanized antibody XR10v48 that neutralizes SARS-CoV-2 variants and protects hamsters via nasal administration.

1 citation

mouseproteomics

𝕏 PostBluesky

NeurosciencebioRxivPreprintFeb 14, 2025

Magnetoencephalography Reveals Neuroprotective Effects of COVID-19 Vaccination in Non-Human Primates

Jennifer R. Stapleton-Kotloski, Jared A. Rowland, April T. Davenport…·James B. Daunais

This study uses MEG to show that a SARS-CoV-2 vaccine preserves neural activity in non-human primates after viral challenge, indicating neuroprotective effects.

3 citations

non-human primateimaging

𝕏 PostBluesky

ImmunologymSpherePeer-reviewedJan 29, 2025

Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein, TRIO

Alexandra Francian, Yevel Flores-García, John R. Powell…·Bryce Chackerian

This study develops a TRIO VLP vaccine targeting Anopheles mosquito salivary protein to enhance immunity against Plasmodium, showing strong antibody responses but limited protective efficacy in a malaria challenge model.

7 citationstop 5%

mouseexperimental assay

𝕏 PostBluesky